Michael S. Weiss
2016 - TG Therapeutics
In 2016, Michael S. Weiss earned a total compensation of $3.9M as Chief Executive Officer and President at TG Therapeutics, a 72% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $276,000 |
|---|---|
| Salary | $375,000 |
| Stock Awards | $3,225,935 |
| Total | $3,876,935 |
Weiss received $3.2M in stock awards, accounting for 83% of the total pay in 2016.
Weiss also received $276K in non-equity incentive plan and $375K in salary.
Rankings
In 2016, Michael S. Weiss' compensation ranked 2,331st out of 14,075 executives tracked by ExecPay. In other words, Weiss earned more than 83.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,331 out of 14,075 | 83rd |
Division Manufacturing | 810 out of 5,488 | 85th |
Major group Chemicals And Allied Products | 240 out of 1,900 | 87th |
Industry group Drugs | 175 out of 1,543 | 89th |
Industry Pharmaceutical Preparations | 136 out of 1,173 | 88th |
Source: SEC filing on April 30, 2018.
Weiss' colleagues
We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2016.
2016
Sean Power
TG Therapeutics